Navigation Links
Corticon Shows Business Transformation Potential of Dialogs, The First Intelligent Interactions Platform, at April 23 Webinar
Date:4/2/2009

Corticon offers special pricing on patent-pending Dialogs, the premier platform for creating and managing engaging self-service web applications.

Redwood City, CA (PRWEB) April 2, 2009 -- Corticon Technologies, Inc. (www.corticon.com), the leader in model-driven Business Rules Management Systems (BRMS), today announced special pricing for, and an educational webinar about, its patent-pending Corticon DialogsTM solution.

Together with Corticon's Business Rules Management System (BRMS), Dialogs brings unprecedented speed and business control to the creation and management of intelligent interactions, typically manifested in web-based self-service applications. Corticon enables organizations to produce much more intelligent and engaging interactions between people and systems because business domain experts are fully empowered to define the questions, web pages and all of the logic that makes an information exchange intelligent, situation-relevant and personalized. And like Corticon BRMS, Corticon Dialogs is model-driven, so there is no programming. The result is a uniquely compelling user experience, produced and maintained with a fraction of the resources and in a fraction of the time required to build comparable but less engaging, forms-based solutions.

Corticon Dialogs has the power to transform businesses, and delivers ROIs that can easily surpass 10x for a broad range of applications including:

  • Web-based sales of complex products - Dialogs is an effective solution to web-enable sales for such diverse products as individual health insurance, commercial and personal lending, and build-to-order manufacturing
  • Call center guidance and automation - Dialogs enables orga
    '/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New research shows lower educational outcomes for survivors of childhood cancer
2. New Study Shows That Despite Recession, Consumer Hold-Outs Struggle To Have It All
3. Study Shows Patients & Nurses Benefit From Continuous Vigilance Monitoring
4. Mayo study shows simple finger device may help predict future heart events, such as heart attack
5. Study shows that exercise reduces migraine suffering
6. Mayo Study Shows Simple Finger Device May Help Predict Future Heart Events, Such as Heart Attack
7. New Report In The Journal of Nutrition Shows Soy Is Beneficial For Heart and Bone Health
8. Alarming new data shows TB-HIV co-infection a bigger threat
9. New Trend Data Shows Access to Surgical Care at Risk in Rural and Urban Areas of the United States
10. Study shows how Salmonella survives in environment
11. Research Shows that Weekend Binge Drinking Can Lead to Parents Drink Driving - Warns the Linwood Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... CA (PRWEB) July 28, 2014 With ... us, it is welcome news that a fire ... than current protection is under development by SunSeeker Enterprises, ... NASA to protect spacecraft from the extreme heat of ... to both firefighters and homes. , “Our firefighters routinely ...
(Date:7/28/2014)... 2014 The report “Industrial Enzymes ... & Beverages, Cleaning Agents, Bio-Fuel, Animal Feed), & ... defines and segments the global industrial enzymes market ... for industrial enzymes. It also identifies driving and ... with analysis of trends, opportunities, burning issues, winning ...
(Date:7/28/2014)... from The University of Texas Health Science Center at San ... a combination of pills that cures 9 of 10 hepatitis ... simeprevir, with or without ribavirin, cured 93 percent of patients ... to the study published today in The Lancet . ... , Eric Lawitz, M.D., clinical professor in the School of ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Recent research ... desk all day for years can lead to a ... cardiovascular disease. But using a standing desk, or an ... pain, often driving office workers back to a seated ... are designed to alleviate this leg pain and ...
(Date:7/28/2014)... MONDAY, July 28, 2014 (HealthDay News) -- A ... stiffness in older people may increase the risk ... suggests. A British study found that patients ... vascular disease -- conditions that affect the blood ... factors of patients with polymyalgia rheumatica to reduce ...
Breaking Medicine News(10 mins):Health News:Revolutionary Fire Blanket Offers Over 200 Percent More Fire Protection to Firefighters and Homes 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 3Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 4Health News:New pill regimens published in The Lancet cure hardest-to-treat hepatitis C patients 2Health News:New Standing Desk Anti-fatigue Mats from Martinson-Nicholls Reduce Leg Fatigue and Discomfort Working at Standing and Sit-to-Stand Desks 2Health News:Inflammatory Muscle Disorder May Raise Risk for Heart Attack, Stroke 2
... dating has not only shed its stigma, it has ... other than meeting through friends, according to a new ... The digital revolution in romance is a boon ... potential partners, reports the team of psychological scientists who ...
... , FRIDAY, Feb. 3 (HealthDay News) -- ,Extended synaptic development ... new study suggests. During the first few years of ... information and experiences from the environment in a way that ... This is due to extended synaptic development, according to the ...
... been mapped with unprecedented accuracy in the bloodstream of ... brand new approach, in an attempt to assess and ... through the body, and solve the problem of predicting ... to a previous generation of systems, the researchers state ...
... aged 70 and over will increase by 40% in ... over will more than double1. Health authorities and the ... of people suffering costly and debilitating age-related chronic diseases ... dementia. The significant increase in the numbers of people ...
... (February 1, 2012) Rates of diabetes vary widely across ... by Dr. Longjian Liu of Drexel University,s School of ... diabetes now live in developing countries. Liu,s study found ... in developing countries, and that one in 10 diagnosed ...
... , THURSDAY, Feb. 2 (HealthDay News) -- Sometimes, there,s nothing ... that where the itch resides is key to ... understanding of itch and might even help folks battling itchy ... professor of dermatology at Wake Forest Baptist Medical Center in ...
Cached Medicine News:Health News:Online dating research shows cupid's arrow is turning digital 2Health News:Online dating research shows cupid's arrow is turning digital 3Health News:Why Human Brains Are Smarter Than Chimp Brains 2Health News:New technology to tackle treatment-resistant cancers 2Health News:New study to assess 3 simple, cost-effective strategies to promote healthy aging 2Health News:Diabetes rates vary widely in developing countries, 1 in 10 cases untreated 2Health News:Pleasure in Scratching an Itch May Depend on Location 2
(Date:7/28/2014)... 28, 2014  VigeneTech, Inc, in collaboration with ... Data Analysis Software, an OEM software solution for ... develops and offers varieties of bead-based multi-analyte immunoassay ... support of VigeneTech,s data analysis software, FCS data ... easily reported LEGENDplex™ software is ...
(Date:7/28/2014)... 2014 Research and Markets  has announced the ... report to their offering. ... leads to inflammation and pain in the human body,s joints ... it causes inflammation of the tissues that surround the joints ... of RA begin slowly, usually just mild pain around the ...
(Date:7/28/2014)... , July 28, 2014  Syneron Medical Ltd. (NASDAQ: ... company, announced today that its new PicoWay® device has ... types and colors and pigmented lesions on any skin ... device, with 532nm and 1064nm wavelengths, which utilizes Syneron,s ... using pulses which are trillionths of a second, known ...
Breaking Medicine Technology:VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2Global Rheumatoid Arthritis Drugs Market 2014-2018 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4
... and Only Approved Platelet Producer in Europe Represents ... Switzerland, Feb. 6 Amgen (Nasdaq: ... (EC) has granted marketing authorisation for Nplate(R) (romiplostim) ... (idiopathic) thrombocytopenic purpura (ITP) patients who are refractory ...
... CAMBRIDGE, Mass. and LONDON, Feb. 6 Idenix Pharmaceuticals, ... today announced the execution of a license agreement granting ... a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) in Phase ... treatment of HIV/AIDS. New NNRTIs are needed to ...
Cached Medicine Technology:Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 2Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 3Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 4Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 5Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 6Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 7Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 8Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 2Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 3Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 4Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 5
... cervical stabilization from neutral to ... widening under occiput when collar ... fasterner.,Exo-Static™ Collar with Chin Piece ... neutral position and restricts lateral ...
... Padding&trade is perfect for use for lightweight ... materials or used to line braces, prosthetics, ... against shock and vibration and conforms to ... and chaffing. It is a 2mm thick ...
... support and stabilization for muscles and ligaments ... pain and discomfort. Strong elastic abdominal ... for varying degrees of compression. Two ... for extra-firm support. Tapered in front ...
... Designed with patient need and comfort ... Appliance) family of products effectively address ... The Chairback frame attachment provides optimal ... (LSO) provides superior support for patient ...
Medicine Products: